Last reviewed · How we verify

NCT04026334

Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue

Terminated NA Last updated 1 August 2022
What this trial tests

NA trial testing V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline in Wound in 8 participants. Terminated before completion.

Timeline
25 July 2019
Primary endpoint
28 August 2020
28 August 2020

Quick facts

Lead sponsor3M
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment8
Start date25 July 2019
Primary completion28 August 2020
Estimated completion28 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

3M — full company profile →

Who can join

22 and older, any sex, with Wound or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study goal is to evaluate the ability of the V.A.C. ULTA™ Negative Pressure Wound Therapy System and V.A.C. VERAFLO CLEANSE CHOICE ™ (VFCC) dressing system with saline as an irrigant in increasing viable tissue in full thickness wounds (such as chronic, acute, traumatic, sub-acute, and dehisced wounds and/or ulcers) with difficult to manage bioburden and slough.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wound

Currently open trials in the same condition.

Other 3M trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing